Mason T. Breitzig, PhD

Henry Ford Health, Center for Healthcare Improvement, Detroit, Michigan; Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, Pennsylvania

JCP
Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals with Mood Disorders
Brief Report

June 1, 2026

High fill rates of GLP-1 receptor agonist prescriptions in those with mood disorders could indicate that multimorbidity begets more treatment.
, , , et al
JCP
Guideline Concordance in Major Depressive Disorder
Original Research

January 3, 2024

This study created a new score to measure treatment guideline adherence and found that following guidelines resulted in lower MDD symptom severity.
, , , et al

Insightful. Evidence-based. Human-centered.

Listen to the JCP Podcast Now
Figure: Digital illustration shows a human head with neural connections and podcast title over a dark blue patterned background.

Subscribe to read
more articles

Subscribe